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Abstract
The effects of nonadherence to prescribed blood pressure medication adversely impacts
African Americans (AA) in comparison to their European American counterparts. The
associated health consequences of uncontrolled hypertension include heart failure, stroke,
and renal dysfunction. And the treatment of the complications negatively impacts quality
of life and contributes to increased health care costs. To address the problem at 1 clinic, a
quality improvement (QI) project was developed by the clinic nursing staff, but the
project had never been evaluated. The project included blood pressure measurements
assessed among AA patients before and after implementation of a 4-item Morisky
Medication-Taking Adherence Scale (MMAS) and education by the nurses. The purpose
of this project was to evaluate whether the use of the MMAS and education improved
blood pressure control in the AA hypertensive patients. This QI evaluation project was
guided by Johnson’s medication adherence model and the Kolkaba comfort theory.
Deidentified results of 3 months of patient blood pressures taken before and 3 months
after the QI project was implemented were obtained from the site for statistical analysis.
A paired sample t test was used to determine if a difference in blood pressure existed
between the 2 groups, before and after implementation (n = 33) of the teaching and the
MMAS. Results indicated a statistically significant (p < .05) decrease in blood pressures
after implementation of the QI project. The findings of this project may positively
influence social change by improving adherence to blood pressure medication and
thereby improving healthcare outcomes for AA patients.
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Section 1: Overview of the Evidenced-Based Project
Introduction
Hypertension (HTN) is among the leading causes of cardiovascular morbidity,
occurring in one-third of the United States population (Bandi, Goldmann, Parikh, Farsi,
& Boden-Albala, 2017). The incidence of HTN is disproportionately higher among
African Americans compared to all other ethnic groups; 45% and 33% respectively as
well as within disparate communities (Centers for Disease Control and Prevention
[CDC], 2016). The focus of this DNP project was on antihypertensive medication
nonadherence among adult African Americans with uncomplicated HTN. According to
the CDC (2016), medication nonadherence increases both morbidity and mortality with a
cost of $100 billion to $289 billion annually. Poor adherence to prescribed pharmacologic
interventions to control HTN is found higher among minorities, such as African
Americans compared to European Americans (Braverman & Dedier, 2009). The resultant
effects of antihypertensive therapy nonadherence contribute to significantly higher
incidences of heart attacks, heart failure, initial strokes, and renal disease (CDC, 2016).
This topic is evidence of a real-world concern based on its impact on the fiscally
overburdened healthcare system in the United States. The knowledge gained from this
project can contribute to the body of nursing science because of its significance in
healthcare and improved patient outcomes (Grove, Burns, & Gray, 2013). Additionally,
positive social change can transpire evidenced by the application of current evidencebased findings in practice that leads to improved patient interventions and outcomes, as
well as a secondary effect of reduced health care costs.
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Section 1 will (a) introduce the practice problem of blood pressure medication
nonadherence and its significance to the field of nursing, and (b) identify the practicefocused question and the approach used in this doctoral project.
Problem Statement
The relationship between uncontrolled HTN and medication nonadherence
adversely impacts morbidity in African Americans as well as the overall costs of
healthcare (CDC, 2017). Antihypertensive therapy nonadherence can also result in
psychosocial deterioration, such as decreased productivity and increased incidence of
depression (Luga & McGuire, 2014). The World Health Organization categorized
potential reasons for nonadherence into five broad groupings: health system, condition,
patient beliefs, therapy effect, and socioeconomic factors. Thereby, making medication
nonadherence a problem for patients, healthcare providers and healthcare systems (Ho,
Bryson, & Rumsfeld, 2009). To efficiently intervene in the issue of medication
nonadherence in this population, leaders in healthcare must consider the etiologies
associated with decisions that are unfavorable to medication adherence.
For this DNP project, I evaluated the effectiveness of a quality improvement (QI)
project that focused on strengthening the quality of nursing practice. To do this, I
obtained deidentified data collected and provided by the clinical site on medication
nonadherence, and the before and after results of the intervention that focused on
improving adherence.
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Purpose
Research has shown that African Americans have higher rates of medication
nonadherence compared to other ethnic groups (CDC, 2016). Numerous studies have
been conducted on both intentional and unintentional aspects of medication
nonadherence, which have yielded suboptimal results or interventions. Data have also
shown the need to address reasons for medication nonadherence and to develop
interventions that would avoid this adverse pattern of behavior (Ndumele, Shaykevich,
Williams, & Hicks, 2010). Although the QI intervention has been in place at the clinical
site, there has been no evaluation of its effectiveness. The purpose of this DNP project
was to evaluate the effectiveness of a practice change that incorporated the use of an
adherence assessment tool as part of a QI effort to improve medication treatment regime
adherence for adult African American patients diagnosed with hypertension. The
outcome of this project could be used to develop new patient interventions and enhance
healthcare policies by modifying behaviors exhibited by providers and patients. This
purpose mirrors that of the intent of a QI evaluation project for the Walden University
DNP student. According to the Walden University Manual for Quality Improvement
Evaluation Projects, “gaining insight into the effectiveness of an organization’s practice
change" is among the purposes of a QI project (Walden University, 2017).
Nature of the Doctoral Project
The location for the DNP project was an internal medicine clinic that provides
medical and social services to Medicaid patients in a metropolitan area in the
northeastern United States. This prime location presented the opportunity for
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accomplishing the DNP project because of its location and because of the population it
serves. According to a recent health survey conducted by the local area department of
health, there are currently more than 2 million adults in the region diagnosed with
hypertension. The prevalence of hypertension is 1.6 times higher (35%) among African
Americans adults when compared to European Americans (23%).
Additionally, African Americans who reside in very high poverty areas have a
higher prevalence of hypertension when compared to African Americans in low poverty
areas (NYC.gov, 2017).
This healthcare disparity places African Americans at a disproportionately higher
risk for cardiovascular disease including stroke, renal dysfunction or failure, and cardiac
diseases such as arrhythmias and myocardial infarction (Ferdinand et al., 2017).
According to the CDC (2016), high blood pressure costs the nation $46 billion each year.
This total includes the cost of health care services, medications used to treat high blood
pressure, and missed days of work resulting from medication nonadherence.
Sources of evidence for this project included peer-reviewed articles, professional
journals and professional healthcare websites, such as the American Heart Association
and the CDC. Sources of evidence for the project after obtaining Walden IRB approval
included medical providers, nursing staff members, and deidentified data from the
electronic medical record. The approach to this DNP project was guided by the Walden
University Manual for Quality Improvement Evaluation Projects.
The purpose of this DNP project was to evaluate a QI initiative at the local site
whose focus is on improving medication adherence. Specifically, the project focused on
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identifying reasons for antihypertensive medication nonadherence among African
Americans within underserved areas and on providing the evidence for strategies that can
promote adherence among this population.
The perceptions held by patients on the need to take their prescribed
antihypertensive medications, the rituals that contribute to medication compliance, as
well as the perceived effectiveness of the therapy, are significant influences to be
considered. They can be used by nurses in practice to increase medication compliance.
Significance
Gaining knowledge for antihypertensive medication nonadherence can influence
key stakeholders such as nurses, physicians, healthcare administrators and those with the
higher influential power to change health care policies at the local, state and national
levels; for example, the stakeholders can develop improved interventions and strategies

(Viswanathan et al., 2012). Additionally, governmental healthcare agencies at the
national level can support endeavors that promote medication adherence interventions by
policies and financial resources. In doing so, national healthcare agencies can increase
public awareness of medication adherence for all citizens, develop and implement
evidence-based interventions for medication adherence, and provide training and
guidance for all healthcare providers so they can deliver effective adherence interventions
(Final Report Summary – ABC; Ascertaining barriers for compliance, 2013). As a result
of the newer interventions and healthcare policies—which positively impact, for
example, out of pocket costs of medications, enhanced prescription drug coverage, and
patient and provider education—African Americans may benefit from improved

6
morbidity and mortality associated with uncontrolled hypertension. This DNP project is
expected to contribute to the improvement of nursing practice by translating evidence to
practice at this clinical site and by evaluating the effectiveness of a QI initiative.
Furthermore, the fiscal burden of providing care for this preventable condition is
lessened. Concurrently, the added benefit of positive social change by improving health
outcomes among members of a diverse population can be accomplished.
Summary
Section 1 provided a brief synopsis of the physiologic and economic impact
associated with antihypertensive medication nonadherence as it pertains to African
Americans who reside in underserved areas within a large metropolitan area of the
northeastern United States.
This QI evaluation effort has aided healthcare providers in developing new
interventions aimed at improving patient outcomes by addressing the knowledge gap
regarding reasons for antihypertensive medication nonadherence. Section 2 will provide a
literature review of current knowledge about blood pressure medication nonadherence,
the conceptual model for the project, its significance to professional nursing practice, and
the role of the DNP student in pursuing this topic.
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Section 2: Background and Context
Introduction
Medication nonadherence is found in disproportionately higher rates among
African Americans when compared to other ethnic groups. The associated morbidity and
mortality rates and healthcare costs are also higher (CDC, 2017). Reasons for medication
nonadherence are varied and can be socially and culturally influenced. The intentional
and non-intentional factors associated with blood pressure medication nonadherence are
additional contributory aspects. This necessitates the development of interventions that
can reverse the impact of blood pressure medication nonadherence among this
population. This DNP project sought to answer the following question.
Does the use of a medication adherence assessment tool influence treatment
regime compliance among adult African American patients diagnosed with
hypertension in urban settings?
The purpose of this DNP project was to evaluate the effectiveness of a QI project
conducted by the local clinical site, which focused on improving medication adherence
among African Americans diagnosed with hypertension. For this DNP project, I analyzed
deidentified data that was provided to me by the staff at the clinical setting.
Concepts, Models, and Theories
Mary Jane Johnson’s medication adherence model (MAM, 2002) and the
Catherine Kolkaba comfort theory were used as the theoretical frameworks for this DNP
project. The medication adherence model was founded upon the following cognitive
theories: the health belief model, social learning theory, the theory of reasoned action,
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and the self-regulation model (Johnson, 2002, p. 183). Intentional and unintentional
nonadherence are concepts identified in the model but reflected as purposeful actions or
patterns of behavior. The MAM considers the following assumptions:
•

People are interested in maintaining their health.

•

People value their health.

•

Hypertension is detrimental to health and well-being.

•

Prescribed medications for blood pressure control are in the best interest of
patients with hypertension.

The framework is appropriate to address the practice-focused question because it
examines the cognitive thought processes that influence nonadherence, variables such as
the perceived need for compliance, the perception of medication efficacy and safety,
routines used when taking medications, and how people view health (Johnson, 2002).
Comfort theory is a middle range theory developed by Catherine Kolkaba in the
early 1990s. It was founded on the concept of comfort and is universally applicable to
patients, nurses, and institutions (Smith & Parker, 2015). When applied in practice,
comfort theory (which includes technical interventions, comfort food for the soul, and
coaching) obligates the provider to provide holistic care to patients while simultaneously
catering to the professional well-being of the provider as well as to institutional
contentment. The theory claims that when nurses furnish comfort interventions, the
increased comfort experienced by patients and families steers them engage in healthseeking behaviors. comfort theory can also be employed to develop interventions to
promote medication adherence. From a theoretical perspective, the comfort theory and
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the MAM provided an opportunity for the enhancement of nursing scholarship on what is
already known about the experiences and perceptions of blood pressure medication
nonadherence. It is also noteworthy to clarify some of the terminology used in this DNP
project. Given the impact of medication nonadherence on hypertension inclusive of but
not limited to increased hospitalizations, increased morbidity and inherent mounting
healthcare expense, interventions that can be developed and applied in practice should
take into account the perceptive reasoning behind noncompliance as demonstrated by
patients with hypertension.
The terms noncompliance and nonadherence are often used interchangeably, and
they are recognized as a descriptive of suboptimal therapy. It is essential to have an
understanding of the subtle yet compelling differences between these terms. According to
Hugtenburg, Timmers, Elders, Vervloet, and Van Dijk (2013), "compliance can be
defined as the extent to which the patient follows the recommendations of the prescriber.
Adherence is the extent to which medication intake behavior corresponds with the
recommendations of the health care provider" (p. 376). The WHO defines adherence as
"the extent to which the persons' behavior (including medication-taking) corresponds
with agreed recommendations from a healthcare provider” (Kenreigh, & Wagner 2005).
The Donabedian Model for Quality of Care was employed to aid in the evaluation of this
DNP project. Created by an expert in the field of QI, Dr. Avedis Donabedian, this triad
model is composed of structure, process, and outcomes as its foundation. “Structure is
defined as the settings, qualification of providers and administrative systems through
which care takes place. Process refers to the components of care and Outcome pertains to
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recovery, restoration of function and survival” (Ayaninan & Markel, 2016, p. 206). This
DNP project relied primarily on the outcome component of the model as it focuses on the
impact on the patient and demonstrates the result of the improvement work and whether it
has achieved the aim set inclusive of but not limited to enhanced patient knowledge and
improved health status (Kobayashi, H., Takemura, Y., & Kanda, K, 2011).
Definition of Terms
African American is defined as "an American of African and black African
decent" ("Merriam-Webster Dictionary," 2018).
Hypertension is the" force of blood pushing against blood vessel walls. It is
measured in millimeters of mercury. High blood pressure means the pressure in your
arteries is higher than it should be" ("American Heart Association," 2017).
The most unambiguous definition of nonadherence is by the American Heart
Association: "not taking medication as directed" (Heart.org, 2018).
Relevance to Nursing Practice
According to the Centers for Disease Control and Prevention (2016), high blood
pressure costs the nation $46 billion each year. This total includes the cost of health care
services, medications to treat high blood pressure, missed days of work resulting from
medication nonadherence, and associated morbidity. African Americans are more likely
than their European American counterparts to have uncontrolled hypertension, and their
cardiovascular health and socioeconomic burdens are disproportionately higher (Lewis,
2012). The American Heart Association (AHA) forecasted the continued increased
prevalence of cardiovascular health disparities among non-Hispanic Blacks.
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Furthermore, the AHA projected a ten percent increase in the prevalence of
hypertension over the next decade. The direct health care costs associated with
hypertension by the year 2030 is expected to surpass 200 million dollars among all
cardiovascular diseases (heart failure, stroke, cardiomyopathy, pulmonary heart disease,
dysrhythmias, and coronary heart disease), making hypertension the most expensive
component of all CVD (Heidenreich et al., 2011).
A qualitative study by Lewis, Askie, Randleman, and Shelton-Duston (2010),
identified medication nonadherence in low-income African Americans that reside in an
urban city. The study explored the behavioral, normative and control beliefs associated
with nonadherence to antihypertensive medications in African Americans diagnosed with
hypertension. The result of this study revealed a need for further studies to examine
patient beliefs about medication adherence. The perceptions held by a patients need to
take their prescribed antihypertensive medications, the behavioral beliefs which
contribute to medication compliance, as well as the perceived effectiveness of the
therapy, are significant influences to be considered for use by nurses in practice to
increase medication compliance (Lewis et al., 2010).
This DNP project sought to evaluate the effectiveness of a QI initiative aimed at
positively impacting blood pressure medication nonadherence among African Americans.
The project aimed to show that the QI initiative can be effective in reducing
nonadherence among this ethnic group. In doing so, the associated adverse effects of
increased morbidities such as renal failure with or without subsequent renal replacement
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therapies, heart failure or stroke and increased health care costs may also be realized
(Ndumele et al., 2010).
Various medication adherence assessment tools have been used as it pertains to
hypertension as well as for other chronic conditions treated with prescribed
pharmacologic agents. Among some of the commonly used adherence assessment tools
are the Self-Efficacy for Appropriate Medication Use Scale (SEAMS), the Hill-Bone
Compliance Scale, Morisky's Medication Adherence Scale, or the Brief Medication
Questionnaire. The most notable among these is the 8-Item Morisky's Medication
Adherence Assessment tool which is frequently used due to its "higher validity and
reliability in patients with chronic diseases and ability to assess adherence among a
variety of chronic conditions" (Lam & Fresco, 2015). The Morisky Green Levine 4-item
adherence assessment tool was used in this QI program at the clinical site. The Morisky
Green Levine tool is a 4-item medication adherence questionnaire used to assess selfreported medication adherence.
It functions to facilitate the identification and addressing of problems and barriers
to adequate compliance. The tool has a relatively high measure of internal consistency of
(0.61) which reflects its reliability (Morisky, Green, & Levine, 1986), thereby making it
an appropriate selection for use. This doctoral project advanced nursing practice by
addressing the need to further assess behaviors and beliefs as barriers to blood pressure
medication adherence among low-income African Americans.
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Local Background and Context
In 2015, the Department of Health and Mental Hygiene in a large metropolitan
area estimated that 65% of the adult population reported having hypertension. African
Americans were found to have a prevalence of hypertension 1.5 times higher than that of
European Americans 1.6 times higher compared to Asian/ Pacific Islanders, and African
American women were found to have a prevalence 2.1 times higher compared to that of
Whites and Asian/ Pacific Islanders (Department of Health and Mental Hygiene, 2016).
Reasons for blood pressure medication nonadherence among African Americans are
multifaceted. Such constraints create challenges for healthcare providers to develop
effective interventions to improve health outcomes. Interventions directed at behavior
modification can be purposefully fashioned when a provider knows why nonadherence
occurs within this population. This QI evaluation project took take place in a clinic
setting which provides primary and mental health care services to adult patients with
Medicaid insurance.
Greater than 95% of patients who receive care in this clinic setting are of a
minority background, primarily Blacks and Hispanics with a low socioeconomic and
health literacy status. The clinic is located within an academic medical center in a large
metropolitan area of the northeastern United States. Because the Morisky four- item tool
used can assess self-reported medication adherence, and functions to facilitate the
identification and addressing of problems and barriers to adequate compliance, this DNP
project sought to evaluate its effectiveness on adherences after implementation. As a
resultant, newly created or augmented interventions which subsume these revelations can
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be implemented leading to reduced healthcare costs and improved patient outcomes by
decreasing associated morbidity and mortality of uncontrolled hypertension.
Role of the DNP Student
As an adult nurse practitioner with an extensive clinical background in critical
care, cardiology and community health nursing, I see firsthand that patients with
uncontrolled hypertension are found to have multifactorial difficulties in maintaining
adherence to prescribed blood pressure medications.
The consequences of uncontrolled hypertension such as arrhythmias, strokes,
myocardial infarctions, heart failure are among the many comorbid conditions I treat
daily in the outpatient setting. This DNP project has empowered me with a deepened
awareness of the need for African Americans to improve their blood pressure medication
adherence.
The role of the DNP student for this project was to evaluate the effectiveness of
the QI project at a clinical site, subsequently facilitating improved interventions aimed at
increasing adherence to blood pressure medications among African Americans. As a
patient and institutional advocate, I hope that this evaluation has served to improve
patient outcomes and positively influence system and policy changes which support
medication adherence for African Americans with hypertension. Additionally, I am
hopeful that this evaluation project will have a significant impact on reversing the health
disparities thereby contributing to real social justice for members of this population.
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Summary
Section 2 provided information which reflects the need to incorporate reasons for
adverse behavior and perceptions held which support blood pressure medication
nonadherence into health care interventions among African Americans in the urban
setting.
The theoretical frameworks, the role of the DNP student as well as its relevance to
nursing practices were introduced and discussed. The analysis of collected evidence for
this DNP project will be presented in Section 3.
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Section 3: Collection and Analysis of Evidence
Introduction
Hypertension is prevalent among one-third of the United States population, and it
is among the leading causes of cardiovascular morbidity (Bandi, Goldmann, Parikh,
Farsi, & Boden-Albala, 2017). The CDC (2016) cited medication nonadherence as a
contributory factor in higher incidences of heart attacks, heart failure, initial strokes, and
renal disease. African Americans have been found more likely to be nonadherent with
prescribed blood pressure medications compared to Whites (Braverman & Dedier, 2009),
placing this segment of the population at a higher risk for associated health
complications. The relationship between uncontrolled hypertension and medication
nonadherence adversely impacts the health status of African Americans. Reasons for
medication nonadherence in this population are to be taken into consideration when
devising interventions because they directly influence this unfavorable behavior. The
unintentional and intentional factors of blood pressure medication nonadherence are
socially and culturally influenced. Therefore, it is appropriate to regard these elements as
essential components when developing interventions that can reverse nonadherent
behaviors.
Practice-Focused Question
Understanding one's convictions about hypertension as a chronic disease and its
treatment are components of health that are indispensable to the development of
interventions directed at improving nonadherence. A qualitative study that sought to
illuminate minority patients’ beliefs about hypertension further highlighted this
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knowledge gap (Kronish, Leventhal, & Horowitz, 2012). According to Kronish et al.
(2012), there is a need to “address the discordances between lay and clinical beliefs about
asymptomatic conditions” (p. 43). Additionally, a qualitative study conducted by Gagnon
et al. (2017) revealed that low-income African American women in New York City with
negative beliefs about medication were more likely (p < .01) to be nonadherent to blood
pressure medication compared to those with positive views of medication. The
recognition of patient beliefs enables the clinician to mitigate the relationship between
blood pressure medication and nonadherence through interventions that augment
behaviors conducive to adherence, resulting in improved patient outcomes. The practicefocused question was as follows: Does the use of a medication adherence assessment tool
influence treatment regimen compliance among adult African American patients
diagnosed with hypertension?
The purpose of this DNP project was to evaluate the effectiveness of a QI practice
change that was implemented at a local clinical site and had not yet been evaluated. The
practice change incorporated the utilization of an adherence assessment tool as part of the
QI effort to improve medication treatment regime adherence for adult AA patients
diagnosed with hypertension. The DNP evaluation project aimed to assist the site in
determining the need to continue the use of the medication adherence assessment tool as
a part of the routine practice for patients treated at the site. The QI initiative and the DNP
evaluation project featured the goals of improving healthcare outcomes among AA
diagnosed with hypertension and the subsequent reduction of its associated healthcare
costs.
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Sources of Evidence
For this DNP project, deidentified data from a clinical QI initiative conducted by
a local clinical site was evaluated. This DNP project intended to determine the
effectiveness of a medication adherence assessment tool implemented at the site by
determining whether the AA patients were compliant to their antihypertension
medications and if that reduced blood pressure.
The QI initiative began in August 2018. Deidentified data was collected by the
facility between May and July 2018. The same deidentified data was collected by the
facility after the initiative was in place between October 2018 and January 2019. The
Morisky Green Levine 4-item Medication-Taking Adherence Scale (MMAS) was used in
this QI project at the clinical site. The Morisky Green Levine tool is a 4-item medication
adherence questionnaire used to assess self-reported medication adherence. It functions to
facilitate the identification and addressing of problems and barriers to adequate
compliance and assess barriers to adherence and medication-taking behaviors. This tool is
appropriate in that it has a 93% sensitivity and 53% specificity in “very low-income
minority patients treated for hypertension seeking routine care in a clinic setting and has
been validated in other chronic conditions as well” (Lam & Fresco, 2015, p. 6). The
Morisky Green Levine 4-item medication adherence tool was used as a conduit through
which extracted perceptions favorable to medication nonadherence could be obtained to
aid in the quality of health outcomes of patients with hypertension.
For this DNP evaluation project, peer-reviewed articles and other findings
published by the CDC, WHO, and the American Heart Association was employed.
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Additionally, after obtaining Walden University’s IRB approval, deidentified data
collected by the clinical site was be provided to for the DNP student for analysis.
Specifically, deidentified data about age, gender, and blood pressure data from 33 patient
records was provided from three months before the implementation of the QI initiative
and for 3 months after the initiative was in place. Additionally, a summary of the data
from the Morisky Green Levine tool was provided for inclusion in the analysis. This
DNP evaluation project helped to explain the benefit of using a medication adherence QI
initiative to improve hypertension among African Americans in an urban area.
The collection and analysis of this essential data was used to determine if the
intervention was effective in reducing nonadherence and may be used by the
administration to determine the need to continue the practice of the medication adherence
assessment tool at the site.
Participants
Because this QI project was already in place, and after IRB approval was obtained
for this project, the site provided deidentified data from thirty- three (n = 33) patient
records where the Morisky Green Levine 4- item Medication-Taking Adherence Scale
was used. This prime location presents the opportunity for accomplishing the DNP
evaluation project because greater than 95% of patients who receive care in this clinic
setting are of a minority background, primarily Blacks and Hispanics with a low
socioeconomic and health literacy status, with the overwhelming majority are among
those who have been diagnosed and are being treated for hypertension at the site. Hence,
this targeted population at this location was relevant to the practice focused question
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because of its potential to influence improved interventions and enhance medication
adherence.
Procedures
The site chose the Morisky Green Levine tool for use in the QI initiative. The tool
is a 4-item medication adherence questionnaire used to assess self-reported medication
adherence. It functions to facilitate the identification and treatment of problems and
barriers to adequate compliance and to assess barriers to adherence and medicationtaking behaviors. The Morisky Green Levine tool is appropriate in that it has a 93%
sensitivity and 53% specificity in “very low-income minority patients treated for
hypertension seeking routine care in a clinic setting and has been validated in other
chronic conditions as well” (Lam & Fresco, 2015, p. 6).
This DNP evaluation project aligned with The American Association of the
Colleges of Nursing essential foundational competencies for all DNP students. This
project aligned with essentials I, II, VI, VII and VIII. This project also aligned with the
Institute of Medicine’s call for nurses to take a greater role in America’s increasingly
complex healthcare system (Institute of Medicine, Committee on Quality of Health Care
in America [IOM], 2001). Furthermore, this DNP evaluation project synchronously
aimed to improve practice within the organization and improve health outcomes among a
population impacted by the chronic condition of hypertension.
Protections
To ensure the ethical protection of participants, the blanket ethics IRB approval
for QI Evaluation projects as directed by the Walden University Quality Improvement
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Manual was obtained. The blanket IRB approval provided the DNP student with “access
to deidentified patient records, operational records pertaining to staff training and
delivery of care, meeting minutes, digital/audio/video recordings created by site, training
materials, protocols, manuals, reports, agreements, questionnaires that were collected
under auspices of site as part of QI operations, and other internal documents that the site
had released to the student for use in the doctoral project” (Walden University Quality
Improvement Manual, 2015). Once IRB approval was obtained, a convenience sample of
deidentified patient data of those participating in the QI initiative was provided to the
DNP student for evaluation.
Analysis and Synthesis
The site QI initiative included using a paper-based format of the 4 item Morisky
Green Levine tool administered to patients by front line clinical staff members at the
clinical site as part of the QI initiative. Blood pressure measurements were assessed and
documented following the site clinical blood pressure measurement protocol by the
clinical staff, and these data in addition to the results of the 4 item adherence assessment
tool data was provided to the student for analysis in this DNP project.
After obtaining IRB approval, the deidentified data obtained from the site was
entered into a spreadsheet within the SPSS statistical analysis software version 25. The
analysis began at that point. Frequency distributions and central tendencies were used in
the analysis as well as a paired sample t test to determine if a difference in blood pressure
exists between the pre and post implementation groups (Terry, 2015, p. 201). Content
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analysis was used to quantify the reasons for nonadherence to blood pressure
medications.
Summary
Section 3 provided an outline of the methods by which the data collection and
analysis of evidence was used to determine if a medication adherence assessment tool can
influence treatment regime compliance among African American adults diagnosed with
hypertension in the urban setting with subsequently controlled hypertension.
After IRB approval was obtained, an evaluation of blood pressure measurements
was provided by the site. Data included deidentified data from the two time points before and after the implementation of the QI program- to determine if the program is
effective. Statistical analysis and project significance were determined using the SPSS
statistical analysis program. Based on the evaluation of the effectiveness of the QI project
which utilizes a medication adherence assessment tool, this QI evaluation project can be
used to improve healthcare outcomes, and organizational processes through the
development or enhancement of newer interventions and health policies. Results of the
data analysis, findings, implications for care outcomes and recommendations will be
addressed in Section 4.
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Section 4: Findings and Recommendations
Introduction
The relationship between uncontrolled HTN and antihypertensive medication
nonadherence contributes to adverse health in African Americans as well as to the overall
costs of healthcare (CDC, 2017). This racial and healthcare disparity places African
Americans at a disproportionately higher risk for cardiovascular disease. Numerous
studies have been conducted on both the willful and inadvertent aspects of medication
nonadherence, which have yielded suboptimal results or interventions. As a resultant,
there remains a need to address reasons for medication nonadherence and develop
interventions that will discontinue and or reverse the associated deleterious effects
(Ndumele, Shaykevich, Williams, & Hicks, 2010). This QI DNP project sought to answer
the following question: Does the use of a medication adherence assessment tool influence
treatment regime compliance among adult African American patients diagnosed with
hypertension in urban settings? Deidentified data collected by the clinical site included
information from patient records, department staff meetings, and associated training; all
was provided to the DNP student. A spreadsheet within the SPSS statistical analysis
software, version 25, was used to organize the collected deidentified data. Frequency
distributions, central tendencies as well as a paired-sample t test were used in the analysis
to determine if a difference in blood pressure existed between the pre- and postimplementation groups
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Findings and Implications
Data from a convenience sample of African American patients (n = 33) who were
treated in the local clinic where the QI project took place, were provided to the DNP
student. One hundred percent of the participants answered all four questions on the 4item medication adherence assessment tool. Data were provided in aggregate form, both
before and after the intervention.
Frequency statistics showed that the sample population was 42% male and 58%
female, with a mean age of 55 years (median age 54; range of 28–83). Seventy-two
percent reported that they forgot to take their blood pressure medications. Eighty-four
percent reported they have problems remembering to take their blood pressure
medication. Eighty-two percent admitted they sometimes stop taking their blood pressure
medications when they felt better, and 76% reported they stopped taking their blood
pressure medication when they felt worse (see Tables 3-6). The result of the paired
sample t test, as shown in Table 1, showed that the mean blood pressure readings were
140/80 and 133/72 before and after the QI implementation, respectively.
Table 1
t Test (paired sample statistics)

Pair 1 Post Sys_BP
Pair 1 Pre_SysBP
Pair 2 Post Dias_BP
Pair 2 Pre Dias_BP

Mean

n

Std. Deviation

Std. Error
Mean

133.33
139.5
72.24
79.85

33
33
33
33

13.263
15.048
6.260
9.909

2.309
2.620
1.725
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The mean differences of both the systolic and diastolic blood pressures [SBP
mean difference = -6.515, SD = 8.920, 95% CI and DBP mean difference = -7.606, SD =
10.52, 95% CI] were statistically significant at the .05 level of significance (SBP t = 4.196, p = .000 and DBP t = -4.151, p = .000) 3 months after implementation of the QI
initiative.
Table 2
Paired Sample Correlations
n

Correlation

Sig

33

.809

.000

33

.214

.231

Pair 1
Post_SysBP & Pre_SysBP
Pair 2
Post_DiasBP & Pre_DiasBP

Table 3
Frequency Table, Morisky Medication-Taking Adherence Scale, MMAS (4-items)
Q1. Do you ever forget to take your anti-hypertension medication?
Frequency

Percent

Yes

24

72.7

No

9

27.3

Total

33

100
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Table 4
Frequency Table, Morisky Medication- Taking Adherence Scale- MMAS (4-items)
Q2. Do you ever have problems remembering to take your anti-hypertension medication?
Frequency

Percent

Yes

28

84.8

No

5

15.2

Total

33

100.0

Table 5
Frequency Table, Morisky Medication- Taking Adherence Scale- MMAS (4-items)
Q3. When you feel better, do you sometimes stop taking your anti-hypertension
medicine?
Frequency

Percent

Yes

27

81.8

No

6

18.2

Total

33

100.0
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Table 6
Frequency Table, Morisky Medication- Taking Adherence Scale- MMAS (4-items)

Q4. Sometimes if you feel worse when you take your antihypertension medication, do
you stop taking it?
Frequency

Percent

Yes

25

75.8

No

8

24.2

Total

33

100.00

The null hypothesis which suggested that there was no significant difference in
the mean systolic and diastolic blood pressures of African American three months after
implementation of the QI initiative is rejected. The result of this QI evaluation showed
the benefits of utilizing a medication adherence tool to improve blood pressure
medication adherence. Correspondingly, improved institutional contentment, the
reduction in healthcare costs, and positive social change can be enhanced.
Recommendations
Identifying a patient’s perception of nonadherence of prescribed blood pressure
medication is essential to improving adherence. These perceptions can be integrated to
facilitate improved holistic interventions aimed at increasing adherence to blood pressure
medications among African Americans. Although the evaluation showed a statistically
significant improvement of the mean blood pressures, due to the small sample size of the
population the results may be not be clinically significant. As such, the DNP student
recommends that the QI initiative be implemented not only at other clinics at the site
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where patients with hypertension seek healthcare services, but to also include patients
with various ethnic backgrounds.
Strengths and Limitations of the Project
Limitations of this QI initiative was the small sample (n = 33). Also, the QI
initiative was implemented at a single clinical setting and only included a convenience
sample of African Americans. Therefore, the results may not be considered generalizable
to a larger mixed-race population of people with uncontrolled hypertension. However, the
major strengths of the QI initiative were its success in showing improved systolic, and
diastolic blood pressure results in African Americans after implementation evidenced by
a reduced mean systolic and diastolic blood pressure. Moreover, the result of the QI
initiative evaluation can be utilized to advocate for policy change at the institutional level
that promotes the integration of a patient’s perception into primary and secondary
preventions that positively affect health outcomes. Lastly, the added benefit of reducing
health care cost resulting from improved adherence and a decrease in the number of clinic
visits for uncontrolled hypertension can positively impact social change by improving
health and quality of life for disparate populations.
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Section 5: Dissemination Plan
Dissemination Plan
Having conducted this evaluation at a large academic facility allows for sharing
knowledge among the various established layers of nursing professionals at the micro and
macro levels at the site. Plans for dissemination of this QI evaluation result to the facility
would be undertaken using the following forums which target nurses, healthcare
professionals, policy makers and consumers (Grove, Burns, & Gray, 2013, p 619). First,
the findings would be relayed directly to the unit where the evaluation occurred in the
form of a brief power point presentation during one of their weekly staff meetings.
Likewise, the same power point presentation would be used for knowledge dissemination
to the Nurse Practitioner Professional Practice Committee (NP-PPC) which I currently
co-chair with the senior director of advanced practice nursing at the facility at one of the
monthly meetings. Consecutively, the conclusions would also be shared on the internal
website that is used by over 500 clinical, administrative and executive level advanced
practice professionals currently employed at the facility. As and invited speaker and
moderator at a local cardiology symposium during nurse practitioner week November
2019, the plan for external dissemination of the findings would include the same
PowerPoint presentation that would be downloaded to a flash drive given to all
participants. In addition to this, the findings would be illustrated in a poster presentation
for review at the symposium thereby allowing for external dissemination and having the
potential to impact global health (Christenbery & Latham, 2012).
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Analysis of Self
As I reflect upon my educational journey over the last four years, I am delighted
by the abundance of knowledge gained. The ability to apply evidence into practice
through effective leadership is both personally and professionally rewarding. As an
advanced practice provider, I have increased confidence in my propensity to influence
change among African Americans with hypertension through scholarship. The result of
this evaluation has provided me with knowledge about perceptions and behaviors
favorable to nonadherence as well as advanced academic capabilities. When combined
with my expertise and clinical background, this knowledge empowers me to exercise
leadership skills that will resonate, promote and optimize patient outcomes favorable to
blood pressure adherence among a disparate population at the organizational and local
levels. Having experienced the role of a project manager has benefited me with by
broadening my insight on the potential to shape health policies at the state level which is
among one of the many long term goals I have envisaged. The challenges and results of
this DNP journey have cultivated my appreciation for and comprehension of the
foundational DNP essentials established by The American Association of the Colleges of
Nursing (AACN, 2006) because it subsumed all eight competencies.
Summary
The result of this DNP evaluation project substantiates the utilization of a
medication adherence assessment tool to influence treatment regime adherence among
African American adults diagnosed with Hypertension. The cognitive thought processes
used by patients about blood pressure medication non- adherence can be employed by
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providers to create and adjust interventions that not only meet the needs of patients.
Additionally, they may also be used to shape new policies within institutions. The
statistical significance revealed makes the implementation noteworthy in that
cardiovascular health outcomes can improve while simultaneously reducing cost making
the tool practical and pertinent for use in clinical settings where patients diagnosed with
hypertension are treated.
As a patient and institutional advocate, I was pleased to see that the evaluation of
this QI initiative improved patient outcomes. Organizational health policies may be
adjusted to positively influence system changes which support medication adherence by
using evidence-based findings guided by nursing theory. Additionally, I am hopeful that
this DNP quality evaluation project will have a significant impact on reversing the health
disparities thereby contributing to real social justice for African Americans with
hypertension as well as advancing nursing science.
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